Literature DB >> 16721565

[Analysis of ocular surface alterations following proton beam radiation in eyes with conjunctival malignant melanoma].

H Westekemper1, G Anastassiou, W Sauerwein, P Chauvel, N Bornfeld, K-P Steuhl, D Meller.   

Abstract

BACKGROUND: In cases of large, diffuse or multilocular growth pattern of conjunctival melanoma, proton beam irradiation can serve as an alternative therapy to exenteration. In extended tumours, ocular surface problems can result after therapy. In this study we examined ocular surface integrity of ten patients who underwent proton beam radiation between 1996 and 2002.
METHODS: The patients were examined during their follow-up. Eight of the ten cases who underwent proton radiotherapy were recurrent tumours, which were previously treated with other adjuvant therapies. We performed a standard ophthalmological examination and detailed tear film diagnostics.
RESULTS: The follow-up was 17-87 months (mean: 40.9+/-20.1). In six cases more than 50% of the upper and lower eyelids were included in the radiation field. All of these cases showed moderate to severe sicca symptoms. The impression cytology revealed squamous metaplasia of conjunctival cells in nine of ten cases.
CONCLUSIONS: Squamous metaplasia of conjunctival epithelia indicates a radiogenic, persisting disturbance of differentiation of the conjunctival epithelial cells. The tear film instability correlates with the loss of mucin-secreting goblet cells and meibomian gland dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721565     DOI: 10.1007/s00347-006-1341-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  24 in total

1.  Sialomucin complex (Muc4) expression in the rat female reproductive tract.

Authors:  N Idris; K L Carraway
Journal:  Biol Reprod       Date:  1999-12       Impact factor: 4.285

2.  [Impression cytology of the conjunctiva following high-dose brachytherapy of malignant melanoma of the uvea using 106Ru/106Rh applicators].

Authors:  J M Koch; N Bornfeld; T N Waubke; A Wessing
Journal:  Fortschr Ophthalmol       Date:  1988

3.  Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation.

Authors:  S C Pflugfelder; S C Tseng; K Yoshino; D Monroy; C Felix; B L Reis
Journal:  Ophthalmology       Date:  1997-02       Impact factor: 12.079

4.  Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study.

Authors:  Gerasimos Anastassiou; Arnd Heiligenhaus; Nikos Bechrakis; Elisabeth Bader; Norbert Bornfeld; Klaus-Peter Steuhl
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

5.  Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation.

Authors:  S C Pflugfelder; S C Tseng; O Sanabria; H Kell; C G Garcia; C Felix; W Feuer; B L Reis
Journal:  Cornea       Date:  1998-01       Impact factor: 2.651

6.  Long-term follow-up of patients with conjunctival melanoma.

Authors:  Cornelia Werschnik; Peter K Lommatzsch
Journal:  Am J Clin Oncol       Date:  2002-06       Impact factor: 2.339

7.  [Dry eye symptoms following retinal surgery and ocular tumour therapy].

Authors:  H Heimann; R Gochman; M Hellmich; N E Bechrakis; M H Foerster
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

Review 8.  Tumors of the conjunctiva and cornea.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Surv Ophthalmol       Date:  2004 Jan-Feb       Impact factor: 6.048

9.  Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome.

Authors:  Satoshi Kawasaki; Shoko Kawamoto; Norihiko Yokoi; Che Connon; Yuichi Minesaki; Shigeru Kinoshita; Kousaku Okubo
Journal:  Exp Eye Res       Date:  2003-07       Impact factor: 3.467

10.  The relation between tear film tests in patients with dry eye disease.

Authors:  Kelly K Nichols; Jason J Nichols; G Lynn Mitchell
Journal:  Ophthalmic Physiol Opt       Date:  2003-11       Impact factor: 3.117

View more
  3 in total

Review 1.  [Operative therapy and irradiation of conjunctival melanoma].

Authors:  H Westekemper; D Meller; R Darawsha; S L Scholz; D Flühs; K-P Steuhl; J Hérault; J Thariat; W Sauerwein
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

Review 2.  [Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma].

Authors:  L M Heindl; K R Koch; M Schlaak; C Mauch; C Cursiefen
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

3.  The use of strontium-90 Beta radiotherapy as adjuvant treatment for conjunctival melanoma.

Authors:  Victoria M L Cohen; Vasilios P Papastefanou; S Liu; Ian Stoker; John L Hungerford
Journal:  J Oncol       Date:  2013-01-31       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.